Shidore et al. (2016) produced and developed a bunch of hybrid compounds by combining the pharmacophoric properties of the diarylthiazole similar to the cholinesterase inhibitor donepezil as potential therapeutics for alleviating the conditions of Alzheimer’s disease. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.